(p. 3). Therefore, evidence is consistent with a DSM-5 PTSD diagnosis that is reliable, has evidence of construct validity, is not substantially different in terms of prevalence based on the DSM-IV criteria, but that includes changes in Criterion A, in PTSD symptoms, and in PTSD symptom clusters. From clinical and research perspectives, the challenge is to develop and evaluate new assessment tools that can measure exposure to DSM-5 traumatic events and DSM-5 PTSD symptoms. We believe that the National Stressful Events Survey assessment measure could be modified to accomplish this task. Specifically, a self-administered assessment tool that can measure exposure to DSM-5 traumatic events, PTSD symptoms, and functional impairment and that can capture the complexity of multiple traumatic event exposure on PTSD symptomatology could prove useful to clinicians as well as researchers.
